Current:Home > BackBiogen scraps controversial Alzheimer's drug Aduhelm-LoTradeCoin
Biogen scraps controversial Alzheimer's drug Aduhelm
View Date:2024-12-23 18:18:05
Biogen is pulling the plug on the controversial drug Aduhelm, the first drug cleared by government health officials for treating Alzheimer's in nearly two decades.
The pharmaceutical giant is returning the rights to the drug to Neurimmune, the private firm that invented it, and incurring a $60 million one-time charge to close out the Aduhelm program, Biogen said Wednesday in a statement.
Cambridge, Massachusetts-based Biogen plans to instead focus its resources on other Alzheimer's efforts. That includes Leqembi, a drug that Biogen is partnering with Japan's Eisai on that was approved by the Food and Drug Administration last year.
Granted accelerated approval in 2021, Aduhelm has not met commercial expectations, with insurers including the federal Medicare program largely refusing to cover the drug because of doubt over its effectiveness and its high cost.
When Biogen initially released Aduhelm, it set the price at $56,000 annually, but later slashed the price in half to about $28,200 after an outcry.
Roughly 6 million people in the U.S. have Alzheimer's, which gradually attacks areas of the brain needed for memory, reasoning, communication and daily tasks.
Kate GibsonKate Gibson is a reporter for CBS MoneyWatch in New York.
veryGood! (4257)
Related
- Driver dies after crashing on hurricane-damaged highway in North Carolina
- The towering legends of the Muffler Men
- How PayPal is using AI to combat fraud, and make it easier to pay
- Ozempic seems to curb cravings for alcohol. Here's what scientists think is going on
- NBPA reaches Kyle Singler’s family after cryptic Instagram video draws concern
- The Highs, Lows and Drama in Britney Spears' Life Since Her Conservatorship Ended
- New Mexico Game Commission to consider increasing hunting limits for black bears in some areas
- 'Gran Turismo' swerves past 'Barbie' at box office with $17.3 million opening
- 2 Florida women charged after shooting death of photographer is livestreamed
- Workers exposed to extreme heat have no consistent protection in the US
Ranking
- Sting Says Sean Diddy Combs Allegations Don't Taint His Song
- Spanish soccer player rejects official's defiance after unsolicited kiss
- Tyga Responds After Blac Chyna Files Custody Case for Son King Cairo
- 3 killed in racially-motivated shooting at Dollar General store in Jacksonville, sheriff says
- NFL power rankings Week 11: Steelers, Eagles enjoying stealthy rises
- Verstappen eyes ninth straight F1 win after another Dutch GP pole. Norris second fastest
- Massive emergency alert test will sound alarms on US cellphones, TVs and radios in October
- Loving mother. Devoted father 'taken away from us forever: Families mourn Jacksonville shooting victims
Recommendation
-
Singles' Day vs. Black Friday: Which Has the Best Deals for Smart Shoppers?
-
Biden and Harris will meet with King’s family on 60th anniversary of the March on Washington
-
8 US Marines remain in hospital after fiery aircraft crash killed 3 in Australia
-
Kim Cattrall and Other TV Stars Who Returned to the Hit Shows They Left
-
Powerball winning numbers for Nov. 9 drawing: Jackpot rises to $92 million
-
College football Week 0 winners and losers: Caleb Williams, USC offense still nasty
-
Lionel Messi will miss 'at least' three games this season with Inter Miami, coach says
-
Dallas Cowboys owner Jerry Jones explains Trey Lance trade with 49ers